Citation Impact
Citing Papers
Guidelines for Management of Ischaemic Stroke and Transient Ischaemic Attack 2008
2008 Standout
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
High Levels of Chronic Immune Activation in the T-Cell Compartments of Patients Coinfected with Hepatitis C Virus and Human Immunodeficiency Virus Type 1 and on Highly Active Antiretroviral Therapy Are Reverted by Alpha Interferon and Ribavirin Treatment
2009
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Point-of-Care Testing
2012 Standout
A Multicenter Study of Recombinant Factor VIII (Recombinate): Safety, Efficacy, and Inhibitor Risk in Previously Untreated Patients With Hemophilia A
1994
Transplantation ofex vivoexpanded endothelial progenitor cells for therapeutic neovascularization
2000 Standout
Disruption of the β1L Isoform of GABP Reverses Glioblastoma Replicative Immortality in a TERT Promoter Mutation-Dependent Manner
2018 StandoutNobel
Parenteral Anticoagulants
2012 Standout
microRNA‐101 is a potent inhibitor of autophagy
2011
Mechanisms of Thrombus Formation
2008 Standout
The tissue inhibitor of metalloproteinases-1 improves migration and adhesion of hematopoietic stem and progenitor cells
2013 StandoutNobel
The Emerging Role of Recombinant-Activated Factor VII in Neurocritical Care
2004
Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects
2020 Standout
Risk of High‐Grade Squamous Intraepithelial Lesion in HIV‐Infected Adolescents
2004
Drug development from marine natural products
2008 Standout
A review of transfusion risks and optimal management of perioperative bleeding with cardiac surgery
2008
Mechanisms of Taxol resistance related to microtubules
2003
Taxanes, microtubules and chemoresistant breast cancer
2007
Synthetic approaches to the 2012 new drugs
2014
Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain
2004 StandoutNature
Antigenic liposomes displaying CD22 ligands induce antigen-specific B cell apoptosis
2013
Safety and Efficacy of Recombinant Human α-Galactosidase A Replacement Therapy in Fabry's Disease
2001 Standout
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
Recombinant Activated Factor VII for Adjunctive Hemorrhage Control in Trauma
2001
Current approach to the treatment of chronic myeloid leukaemia
2017
Recombinant Activated Factor VII for Acute Intracerebral Hemorrhage
2005 Standout
Aptamers as therapeutics
2010 Standout
DC-SIGN, a Dendritic Cell–Specific HIV-1-Binding Protein that Enhances trans-Infection of T Cells
2000 Standout
Aptamers as targeted therapeutics: current potential and challenges
2016 Standout
A Ribosomopathy Reveals Decoding Defective Ribosomes Driving Human Dysmorphism
2017 StandoutNobel
Unstable proteins: how to subject them to chromatographic separations for purification procedures
1997
The oncoprotein 18/stathmin family of microtubule destabilizers
2002
The end of AIDS: HIV infection as a chronic disease
2013 Standout
Factor IX Inhibitors and Anaphylaxis in Hemophilia B
1997
Efficacy and Safety of Recombinant Activated Factor VII for Acute Intracerebral Hemorrhage
2008 Standout
A conserved water-mediated hydrogen bond network defines bosutinib's kinase selectivity
2013
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
2021 StandoutNobel
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
Microtubule-binding agents: a dynamic field of cancer therapeutics
2010 Standout
The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition
2016 Standout
Diagnosing and treating Diamond Blackfan anaemia: results of an international clinical consensus conference
2008
Molecular and Cellular Biology of Blood Coagulation
1992
Microtubules as a target for anticancer drugs
2004 Standout
Natural compounds for cancer treatment and prevention
2009 Standout
Neovascularization of ischemic myocardium by human bone-marrow–derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function
2001 Standout
Therapeutic developments for Duchenne muscular dystrophy
2019
Absence of Erythroblast Macrophage Protein (Emp) Leads to Failure of Erythroblast Nuclear Extrusion
2006
Protein therapeutics: a summary and pharmacological classification
2007 Standout
Diagnostic Discordance for Hepatitis C Virus Infection in Hemodialysis Patients
2005
The molecular mechanisms of immunomodulation and tolerance induction to factor VIII
2009
miR-14 Regulates Autophagy during Developmental Cell Death by Targeting ip3-kinase 2
2014 StandoutNobel
High Incidence of Later-Onset Fabry Disease Revealed by Newborn Screening*
2006 Standout
Efficient and Scalable Purification of Cardiomyocytes from Human Embryonic and Induced Pluripotent Stem Cells by VCAM1 Surface Expression
2011 StandoutNobel
Reduced CD4 T cell activation and in vitro susceptibility to HIV-1 infection in exposed uninfected Central Africans
2006 StandoutNobel
BIOCHEMISTRY AND GENETICS OF VON WILLEBRAND FACTOR
1998 Standout
HIV‐1‐specific cellular immune responses among HIV‐1‐resistant sex workers
2000
Steric and Dynamic Parameters Influencing In Situ Cycloadditions to Form Triazole Inhibitors with Crystalline Acetylcholinesterase
2016 StandoutNobel
Nanozymes: Classification, Catalytic Mechanisms, Activity Regulation, and Applications
2019 Standout
Identification and transcriptome analysis of erythroblastic island macrophages
2019 StandoutNobel
Neuronal-associated microtubule proteins class III beta-tubulin and MAP2c in neuroblastoma: role in resistance to microtubule-targeted drugs.
2004
Safety and Feasibility of Recombinant Factor VIIa for Acute Intracerebral Hemorrhage
2004
Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage
2006 Standout
High Frequency of Adhesion Defects in B-Lineage Acute Lymphoblastic Leukemia
1999
Differential mitotic responses to microtubule-stabilizing and -destabilizing drugs.
2002
Stathmin 1: a novel therapeutic target for anticancer activity
2008
Targeted Gene Deletion Demonstrates that Cell Adhesion Molecule ICAM-4 is Critical for \nErythroblastic Island Formation
2006
Expression of VEGFR-2 and AC133 by circulating human CD34+ cells identifies a population of functional endothelial precursors
2000 Standout
Isolation and characterization of human bone marrow microvascular endothelial cells: hematopoietic progenitor cell adhesion
1994
A Higher than Expected Incidence of Factor VIII Inhibitors in Multitransfused Haemophilia A Patients Treated with an Intermediate Purity Pasteurized Factor VIII Concentrate
1993
Guidelines for the Primary Prevention of Stroke
2014 Standout
Ability of Recombinant Factor VIIa to Reverse the Anticoagulant Effect of the Pentasaccharide Fondaparinux in Healthy Volunteers
2002
PUMA Overexpression Induces Reactive Oxygen Species Generation and Proteasome-Mediated Stathmin Degradation in Colorectal Cancer Cells
2005
Human Papillomavirus and Cervical Cancer
2003 Standout
Chronic myeloid leukemia: 2014 update on diagnosis, monitoring, and management
2014
Identification of Mycoplasma pirum genes involved in the salvage pathways for nucleosides
1993 StandoutNobel
Advanced functional polymer membranes
2006 Standout
Use of site-directed mutagenesis to enhance the epitope-shielding effect of covalent modification of proteins with polyethylene glycol.
1991
The affinity and stoichiometry of binding of human factor VIII to von Willebrand factor
1995
Ultra-Early Hemostatic Therapy for Intracerebral Hemorrhage
2003
Cell adhesion in the stromal regulation of haemopoiesis
1992
Fabry Disease, an Under-Recognized Multisystemic Disorder: Expert Recommendations for Diagnosis, Management, and Enzyme Replacement Therapy
2003
RHO GTPASES: Biochemistry and Biology
2005 Standout
Vascular cell adhesion molecule-1 expressed by bone marrow stromal cells mediates the binding of hematopoietic progenitor cells
1992
Plant Secondary Metabolites as Anticancer Agents: Successes in Clinical Trials and Therapeutic Application
2018 Standout
Natural Products as Sources of New Drugs from 1981 to 2014
2016 Standout
Kinetics of factor VIII-von Willebrand factor association
1996
Vascular safety issues in CML patients treated with BCR/ABL1 kinase inhibitors
2014
Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack
2010 Standout
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
2016 Standout
Effect of stathmin on the sensitivity to antimicrotubule drugs in human breast cancer.
2002
Plasma elevation of stromal cell–derived factor-1 induces mobilization of mature and immature hematopoietic progenitor and stem cells
2001 StandoutNobel
CD34-deficient mice have reduced eosinophil accumulation after allergen exposure and show a novel crossreactive 90-kD protein
1996 StandoutNobel
Therapeutic Targeting of Telomerase
2016
Works of Steven Arkin being referenced
Evidence for a Shift from a Type I Lymphocyte Pattern with HIV Disease Progression
1995
Activated Recombinant Human Coagulation Factor VII Therapy for Intracranial Hemorrhage in Patients with Hemophilia A or B with Inhibitors
1998
Loss of high‐responder inhibitors in patients with severe hemophilia A and human immunodeficiency virus type 1 infection: A report from the multi‐center hemophilia cohort study
1993
Recombinant Factor VIII for the Treatment of Previously Untreated Patients with Hemophilia A -- Safety, Efficacy, and Development of Inhibitors
1993
An intrinsic progenitor defect in Diamond‐Blackfan anaemia
1989
Human Recombinant DNA–Derived Antihemophilic Factor (Factor VIII) in the Treatment of Hemophilia A
1990
Upregulated ATM Gene Expression and Activated DNA Crosslink-Induced Damage Response Checkpoint in Fanconi Anemia: Implications for Carcinogenesis
2008
Relation Between HIV-1 and Hepatitis C Viral Load in Patients With Hemophilia
2001
Effects of stathmin inhibition on the mitotic spindle
2001
Taxol and anti-stathmin therapy: a synergistic combination that targets the mitotic spindle.
2000
Human coagulation factor FVIIa (recombinant) in the management of limb-threatening bleeds unresponsive to alternative therapies: results from the NovoSeven emergency-use programme in patients with severe haemophilia or with acquired inhibitors.
2000
Safety and efficacy of bosutinib (SKI-606) in chronic phase Philadelphia chromosome–positive chronic myeloid leukemia patients with resistance or intolerance to imatinib
2011
Recombinant Factor VIII for the Treatment of Previously Untreated Patients with Hemophilia A
1993
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Domagrozumab (PF‐06252616), an Antimyostatin Monoclonal Antibody, in Healthy Subjects
2017
Safety and efficacy of bosutinib (SKI-606) in patients (pts) with chronic phase (CP) chronic myeloid leukemia (CML) following resistance or intolerance to imatinib (IM).
2010
Expression of intercellular adhesion molecule-1 (CD54) on hematopoietic progenitors
1991